DEBORAH HARLAND

Deborah Harland serves as a distinguished Partner at SR One, a leading venture capital firm renowned for its strategic investments in the life sciences sector. In this pivotal role, she is instrumental in identifying and nurturing early-stage companies poised to revolutionize healthcare through scientific innovation.

SR One, which spun out from GSK to become an independent venture capital firm, maintains a strong legacy of backing groundbreaking science. Deborah Harland's contributions are central to this mission, as she leverages her extensive scientific and investment expertise to support the next generation of biotech and healthcare leaders. Her investment focus areas are broad yet targeted, encompassing novel therapeutics, cutting-edge digital health solutions, and transformative medical devices. She is particularly adept at recognizing the potential in early-stage ventures that promise significant advancements in patient care and outcomes.

Harland's career background provides a robust foundation for her success in venture capital. She holds a PhD in Molecular Biology from the University of Cambridge, underscoring her deep scientific acumen. Prior to joining SR One, she held significant leadership positions at GSK, including leading the GSK Ventures team. This experience equipped her with invaluable insights into drug discovery, development, and the intricacies of corporate venture capital, allowing her to provide strategic guidance to portfolio companies from a unique vantage point.

Throughout her tenure, Deborah Harland has been actively involved in numerous promising companies, often serving on their boards or as a board observer. Notable investments and board roles include her involvement with companies such as Nodthera, Galecto, Mission Therapeutics, and others within SR One's diverse portfolio. Her active participation helps these companies navigate critical growth stages, from scientific validation to market entry, ensuring they have the resources and strategic direction needed to succeed.

Deborah Harland's dedication to fostering innovation in life sciences makes her a key figure in the venture capital landscape. Her ability to combine rigorous scientific evaluation with astute investment strategy positions her as a vital partner for entrepreneurs aiming to make a lasting impact on global health.